Articles with public access mandates - Imre NothLearn more
Not available anywhere: 8
Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study
MLK Han, Y Zhou, S Murray, N Tayob, I Noth, VN Lama, BB Moore, ...
The Lancet Respiratory Medicine 2 (7), 548-556, 2014
Mandates: US National Institutes of Health
A Variant in the Promoter of MUC5B and Idiopathic Pulmonary Fibrosis
Y Zhang, I Noth, JGN Garcia, N Kaminski
New England Journal of Medicine 364 (16), 1576-1577, 2011
Mandates: US National Institutes of Health
CT findings associated with survival in chronic hypersensitivity pneumonitis
JH Chung, SM Montner, A Adegunsoye, JM Oldham, AN Husain, R Vij, ...
European radiology 27, 5127-5135, 2017
Mandates: US National Institutes of Health
Approach to clinical trials for the prevention of pulmonary fibrosis
JS Kim, SB Montesi, A Adegunsoye, SM Humphries, ML Salisbury, ...
Annals of the American Thoracic Society 20 (12), 1683-1693, 2023
Mandates: National Institute for Health Research, UK
TOLLIP SNP and Antimicrobial Treatment Effect in Idiopathic Pulmonary Fibrosis
W Whalen, K Berger, JS Kim, W Simmons, SF Ma, RJ Kaner, FJ Martinez, ...
American Journal of Respiratory and Critical Care Medicine 210 (4), 508-511, 2024
Mandates: National Institute for Health Research, UK
Antimicrobial Therapy and Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis—Reply
FJ Martinez, KJ Anstrom, I Noth
JAMA 326 (11), 1071-1072, 2021
Mandates: US National Institutes of Health
C101 IPF: CLINICAL STUDIES, THERAPEUTICS, AND MORE II: Prepabel: A Bioinformatic Tool For Preprocessing Imputed Genotype Dosage Data For Survival Analyses
J Lorenzo-Salazar, SF Ma, JM Oldham, I Noth, C Flores
American Journal of Respiratory and Critical Care Medicine 195, 2017
Mandates: US National Institutes of Health
Is Warfarin the Right Anticoagulant in Idiopathic Pulmonary Fibrosis?/Reply
MD Elisabeth Bendstrup, MD Ole Hilberg, I Noth, M Olman
American Journal of Respiratory and Critical Care Medicine 186 (7), 693, 2012
Mandates: US National Institutes of Health
Available somewhere: 139
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study
I Noth, Y Zhang, SF Ma, C Flores, M Barber, Y Huang, SM Broderick, ...
The Lancet respiratory medicine 1 (4), 309-317, 2013
Mandates: US National Institutes of Health, Government of Spain
A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis
I Noth, KJ Anstrom, SB Calvert, J De Andrade, KR Flaherty, C Glazer, ...
American journal of respiratory and critical care medicine 186 (1), 88-95, 2012
Mandates: US National Institutes of Health
Association between telomere length and risk of cancer and non-neoplastic diseases: a Mendelian randomization study
PC Haycock, S Burgess, A Nounu, J Zheng, GN Okoli, J Bowden, ...
JAMA oncology 3 (5), 636-651, 2017
Mandates: US National Institutes of Health, British Heart Foundation, Cancer Research …
Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis
AL Peljto, Y Zhang, TE Fingerlin, SF Ma, JGN Garcia, TJ Richards, ...
Jama 309 (21), 2232-2239, 2013
Mandates: US National Institutes of Health
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials
JS Lee, HR Collard, KJ Anstrom, FJ Martinez, I Noth, RS Roberts, E Yow, ...
The Lancet Respiratory Medicine 1 (5), 369-376, 2013
Mandates: US National Institutes of Health
TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis
JM Oldham, SF Ma, FJ Martinez, KJ Anstrom, G Raghu, DA Schwartz, ...
American journal of respiratory and critical care medicine 192 (12), 1475-1482, 2015
Mandates: US National Institutes of Health
Autoimmune-featured interstitial lung disease: a distinct entity
R Vij, I Noth, ME Strek
Chest 140 (5), 1292-1299, 2011
Mandates: US National Institutes of Health
Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis
JD Herazo-Maya, I Noth, SR Duncan, SH Kim, SF Ma, GC Tseng, ...
Science translational medicine 5 (205), 205ra136-205ra136, 2013
Mandates: US National Institutes of Health
Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation
BD Stuart, JS Lee, J Kozlitina, I Noth, MS Devine, CS Glazer, F Torres, ...
The lancet Respiratory medicine 2 (7), 557-565, 2014
Mandates: US National Institutes of Health, Doris Duke Charitable Foundation
Characterisation of patients with interstitial pneumonia with autoimmune features
JM Oldham, A Adegunsoye, E Valenzi, C Lee, L Witt, L Chen, AN Husain, ...
European Respiratory Journal 47 (6), 1767-1775, 2016
Mandates: US Department of Energy, US National Institutes of Health
PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
LJ Celada, JA Kropski, JD Herazo-Maya, W Luo, A Creecy, AT Abad, ...
Science translational medicine 10 (460), eaar8356, 2018
Mandates: US National Institutes of Health, US Department of Veterans Affairs …
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study
RJ Allen, J Porte, R Braybrooke, C Flores, TE Fingerlin, JM Oldham, ...
The Lancet respiratory medicine 5 (11), 869-880, 2017
Mandates: US National Institutes of Health, Canadian Institutes of Health Research, UK …
Publication and funding information is determined automatically by a computer program